Name | Mobocertinib |
---|
Description | Mobocertinib is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
---|---|
Related Catalog | |
References |
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). |
Molecular Formula | C32H39N7O4 |
---|---|
Molecular Weight | 585.70 |